Last updated: April 25, 2026
Who supplies Kalydeco (ivacaftor) inputs, manufacturing, and distribution?
Kalydeco (ivacaftor) is supplied through a defined set of upstream API and formulation manufacturing pathways and downstream commercial distribution. The commercial supply chain is led by the product’s marketing authorization holder and branded product manufacturer, while API supply and excipient/formulation components come from specialized suppliers used across the therapeutic and dosage forms.
Who is the marketing authorization holder and commercial supplier for Kalydeco?
Kalydeco is marketed in many jurisdictions by Vertex Pharmaceuticals as the brand owner and marketing authorization holder.
- Vertex Pharmaceuticals (brand owner and MAH): Vertex is the entity that holds and manages the product’s marketing authorizations and branded supply strategy in major markets (e.g., US and EU).
- Commercial distribution: distribution is executed through the respective authorized wholesalers and Vertex-led channels in each country (market-specific).
Key point for diligence: Vertex controls the branded product supply chain through quality agreements and approved manufacturing sites for drug product and through controlled sourcing of clinical and commercial materials.
What suppliers make the drug product (tablets/granules)?
For Kalydeco, the drug product is manufactured at approved commercial manufacturing sites under Vertex control and GMP quality systems. The exact site list can vary by geography and product strength (e.g., tablets vs granules), with manufacturing transfers over time.
- Drug product manufacturing (GMP): performed at Vertex-approved manufacturers using Vertex master batch records, controlled formulations, and validated analytical methods.
- Packaging and labeling: executed at packaging and labeling sites authorized for each market.
Key point for diligence: for procurement or partnership work, the binding list is the approved manufacturing sites shown in regulatory filings per country and the Quality Agreement roster used by Vertex for supply of commercial lots.
What suppliers make the API (ivacaftor) and how is it sourced?
Ivacaftor is a specialized small-molecule API, typically sourced from one or more approved API manufacturers that produce under GMP and are qualified by Vertex.
- API manufacturing (ivacaftor): performed by one or more GMP API suppliers and/or Vertex-designated API production sites.
- API release: depends on batch certification by the approved API manufacturer and release testing under Vertex’s quality framework.
Key point for diligence: the actionable supplier list for API sourcing is the set of approved manufacturers in jurisdiction-specific submissions and confirmed in supply chain disclosures tied to drug substance changes (CMC).
What other suppliers are involved in Kalydeco production?
In addition to the drug product and API manufacturing, the supply chain includes:
- Excipients and formulation components (granule/tablet excipients)
- Packaging component suppliers (bottles/blister components, desiccants, labels)
- Analytical testing services (method transfer and reference standards)
- Contract manufacturing and packaging organizations (CMOs) used for specific dosage strengths or packaging formats
Key point for diligence: excipient and packaging suppliers are frequently managed through supplier qualification programs and change-control documentation; the public record often lists packaging sites less consistently than drug product manufacturing sites.
Operational supplier map for Kalydeco (decision-ready)
| Supply chain layer |
What it covers |
Supplier types |
What you validate for diligence |
| Drug substance (API) |
Ivacaftor synthesis and purification |
API manufacturer(s) |
Approved API site list in regulatory filings; DMF/CMC references; GMP status |
| Drug product |
Tablets/granules and finished dosage form |
Drug product manufacturer(s) |
Approved drug product site list per country/strength; release testing and stability programs |
| Packaging/labeling |
Bottles/blisters, labeling, inserts |
Packaging site(s)/CMO packaging |
Market-specific approved packaging sites and labeling artwork controls |
| Commercial distribution |
Warehousing, distribution through channels |
Authorized distributors/wholesalers |
Product tracing, cold-chain needs (if any by format), and authorized distributor roster |
Kalydeco supply chain: what matters for R&D and investment decisions
1) Supplier selection is driven by regulatory qualification
Kalydeco’s supplier roster is anchored to GMP-approved sites used to manufacture commercial drug product and API. Any supplier swap is usually governed by:
- regulatory change-control filing requirements (CMC)
- comparability data to support bridging of quality and performance
- batch release and method validation
2) Vertex controls quality and approval
For branded CFTR modulators like ivacaftor, Vertex operates under strict:
- quality agreements
- supplier qualification
- ongoing stability and analytical verification
3) Dosage form differences can change packaging and site responsibilities
Kalydeco is marketed in multiple formats across pediatric and adult use. Site assignments for manufacturing and packaging can vary by strength and format, so the “right” supplier set is the one tied to the specific SKU and geography.
Key Takeaways
- Kalydeco’s upstream supply is organized around GMP-qualified API manufacturers for ivacaftor and Vertex-approved drug product manufacturing sites for dosage forms.
- Vertex Pharmaceuticals is the brand owner/marketing authorization holder that controls quality agreements and supplier qualification across markets.
- A diligence-ready supplier list is the set of approved manufacturing and packaging sites by jurisdiction and dosage form, anchored to CMC and regulatory submissions tied to commercial lots.
FAQs
1) Who supplies Kalydeco commercially?
Vertex Pharmaceuticals controls the branded product and supply strategy; commercial distribution is executed through authorized market distribution channels.
2) Who makes the ivacaftor API?
Ivacaftor is manufactured by GMP-qualified API suppliers that are approved in Vertex’s regulatory documentation and quality systems.
3) Are drug product and API suppliers the same?
No. API and finished dosage forms are typically produced by different specialized suppliers under GMP and qualified by the marketing authorization holder.
4) Does Kalydeco packaging supplier vary by country?
Yes. Packaging and labeling sites and formats can differ by market and by dosage form.
5) Where is the supplier list verified for compliance?
In jurisdiction-specific regulatory submissions and the approved manufacturing/packaging site rosters used for commercial release and change control.
References (APA)
[1] Vertex Pharmaceuticals Incorporated. (n.d.). Kalydeco (ivacaftor) prescribing information. U.S. Food and Drug Administration (FDA).
[2] European Medicines Agency. (n.d.). Kalydeco: product information and EPAR documents. European Medicines Agency.
[3] U.S. Food and Drug Administration. (n.d.). Drugs@FDA: Kalydeco (ivacaftor). U.S. FDA.
